WallStreetZenWallStreetZen

NASDAQ: VERU
Veru Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VERU

Based on 3 analysts offering 12 month price targets for Veru Inc.
Min Forecast
$2.00+56.86%
Avg Forecast
$3.33+161.41%
Max Forecast
$5.00+292.16%

Should I buy or sell VERU stock?

Based on 3 analysts offering ratings for Veru Inc.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VERU stock forecasts and price targets.

VERU stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-15
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-02-08

1 of 1

Forecast return on equity

Is VERU forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is VERU forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VERU revenue forecast

What is VERU's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$11.4M-28.65%
Avg 2 year Forecast
$9.0M-43.5%
Avg 3 year Forecast
$9.0M-43.5%
VERU's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VERU revenue growth forecast

How is VERU forecast to perform vs Biotechnology companies and vs the US market?
Company
-18.63%
Industry
37.57%
Market
10.16%
VERU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VERU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VERU vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VERU$1.28$3.33+161.41%Buy
ATOS$1.49$4.00+168.46%Buy
CRDF$4.17$10.50+151.80%Strong Buy
ABOS$3.16$11.50+263.92%Strong Buy
INMB$10.14N/AN/A
View Top Biotech Stocks

Veru Stock Forecast FAQ

Is Veru Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: VERU) stock is to Buy VERU stock.

Out of 3 analysts, 0 (0%) are recommending VERU as a Strong Buy, 3 (100%) are recommending VERU as a Buy, 0 (0%) are recommending VERU as a Hold, 0 (0%) are recommending VERU as a Sell, and 0 (0%) are recommending VERU as a Strong Sell.

If you're new to stock investing, here's how to buy Veru stock.

What is VERU's revenue growth forecast for 2024-2026?

(NASDAQ: VERU) Veru's forecast annual revenue growth rate of -18.63% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Veru's revenue in 2024 is $15,929,890.On average, 3 Wall Street analysts forecast VERU's revenue for 2024 to be $1,663,768,560, with the lowest VERU revenue forecast at $1,185,687,607, and the highest VERU revenue forecast at $2,107,889,078. On average, 2 Wall Street analysts forecast VERU's revenue for 2025 to be $1,317,430,674, with the lowest VERU revenue forecast at $1,171,049,488, and the highest VERU revenue forecast at $1,463,811,860.

In 2026, VERU is forecast to generate $1,317,430,674 in revenue, with the lowest revenue forecast at $1,171,049,488 and the highest revenue forecast at $1,463,811,860.

What is VERU's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VERU) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VERU's Price Target?

According to 3 Wall Street analysts that have issued a 1 year VERU price target, the average VERU price target is $3.33, with the highest VERU stock price forecast at $5.00 and the lowest VERU stock price forecast at $2.00.

On average, Wall Street analysts predict that Veru's share price could reach $3.33 by Apr 15, 2025. The average Veru stock price prediction forecasts a potential upside of 161.41% from the current VERU share price of $1.28.

What is VERU's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VERU) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.